openPR Logo
Press release

Deadline on August 30th coming up in Lawsuit for Investors in Acer Therapeutics Inc. (NASDAQ: ACER)

08-20-2019 06:33 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on August 30, 2019 in the lawsuit for certain investors in Acer Therapeutics Inc. (NASDAQ: ACER).

A Deadline is coming up on August 30, 2019 in the lawsuit for certain investors in Acer Therapeutics Inc. (NASDAQ: ACER).

The Shareholders Foundation announced that a deadline is coming up on August 30, 2019 in the lawsuit filed for certain investors of Acer Therapeutics Inc. (NASDAQ: ACER) over alleged securities laws violations by Acer Therapeutics Inc.

Investors who purchased shares of Acer Therapeutics Inc. (NASDAQ: ACER) have certain options and there are strict and short deadlines running. Deadline: August 30, 2019. NASDAQ: ACER stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges on behalf of purchasers of Acer Therapeutics Inc. (NASDAQ: ACER) common shares between September 25, 2017 and June 24, 2019, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between September 25, 2017 and June 24, 2019, the Defendants made false and/or misleading statements and/or failed to disclose that Acer lacked sufficient data to support filing EDSIVO’s NDA with the FDA for the treatment of vEDS, that the Ong Trial was an inadequate and ill-controlled clinical study by FDA standards, and was comprised of an insufficiently small group size to support EDSIVO’s NDA, that consequently, the FDA would likely reject EDSIVO’s NDA, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.

Those who purchased shares of Acer Therapeutics Inc. (NASDAQ: ACER) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on August 30th coming up in Lawsuit for Investors in Acer Therapeutics Inc. (NASDAQ: ACER) here

News-ID: 1824092 • Views:

More Releases from Shareholders Foundation

Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, 2025
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd. Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Investigation announced for Long-Term Investors in shares of West Pharmaceutical Services, Inc. (NYSE: WST) over potential Wrongdoing
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc.. Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed
Investigation announced for Long-Term Investors in Open Lending Corporation (NASDAQ: LPRO) over potential Wrongdoing
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation. Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings, Inc. (NYSE: BBAI)
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced. Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm

All 5 Releases


More Releases for Acer

Urea Cycle Disorders Market to Expand at a Substantial Growth Rate During the Fo …
As per DelveInsight's assessment, the Urea Cycle Disorders Market is anticipated to grow in the coming years owing to the increasing incidence of Urea Care Disorders patients in the 7MM and the launch of emerging therapies in the market. Some of the key players involved in the development of novel drugs for the treatment of Urea Cycle Disorders include ACER-001 (Acer Therapeutics), AEB1102 (Aeglea BioTherapeutics), DTX301 (Ultragenyx Pharmaceutical), among others. DelveInsight's
Acer Therapeutics Inc. (NASDAQ: ACER) Investor Notice: Update in Lawsuit against …
A lawsuit is pending for certain investors in shares of Acer Therapeutics Inc. (NASDAQ: ACER) over potential securities laws violations by Acer Therapeutics Inc. Investors who purchased shares of Acer Therapeutics Inc. (NASDAQ: ACER), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The lawsuit was filed on July 01, 2019 against Acer Therapeutics Inc. (NASDAQ: ACER) over alleged violations of Federal Securities Laws.
Investigation announced for long-term Investors in shares of Acer Therapeutics I …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Acer Therapeutics Inc.. Investors who are current long term investors in Acer Therapeutics Inc. (NASDAQ: ACER) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in Acer Therapeutics Inc. (NASDAQ: ACER stocks follows a lawsuit
Investigation announced for Investors in NASDAQ: ACER over possible Wrongdoing a …
An investigation was announced for investors in shares of Acer Therapeutics Inc. (NASDAQ: ACER) concerning potential breaches of fiduciary duties by certain directors of Acer Therapeutics Inc. Investors who are current long term investors in Acer Therapeutics Inc. (NASDAQ: ACER) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in Acer
Lawsuit filed for Investors in shares of Acer Therapeutics Inc. (NASDAQ: ACER)
An investor, who purchased shares of Acer Therapeutics Inc. (NASDAQ: ACER), filed a lawsuit over alleged Securities Laws violations by Acer Therapeutics Inc.. Investors who purchased shares of Acer Therapeutics Inc. (NASDAQ: ACER) have certain options and for certain investors are short and strict deadlines running. Deadline: August 30, 2019. NASDAQ: ACER investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Newtown, MA based Acer Therapeutics Inc.,
Hybrid PC Market: Asus, HP, Lenovo, Sony, Acer
MarketResearchReports.Biz has recently announced the Latest industry research report on: "Global Hybrid PC Market" : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts. This report presents the worldwide Hybrid PC market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities